Technologies

Life Sciences & Biotechnology, COVID-19 Technology

Title:

One drop nasal vaccine based on flu vaccine candidate M2SR [CoroFlu]

Area:

Life Sciences & Biotechnology, COVID-19 Technology

Focus Area:

Development of nasal vaccine for COVID-19

Developing Agency:

Bharat Biotech, Hyderabad

Technology Readiness Index:

Commercialized
Website Link :https://www.bharatbiotech.com/

Brief Description

Description :

Unique intranasal vaccine for Coronavirus ‘CoroFlu’ is under development. Bharat Biotech is manufacturing the vaccine, conduct clinical trials, and prepare to produce almost 300 million doses of vaccine for global distribution.

Related Technologies